智通财经网·2025-11-17 02:49Group 1 - The core viewpoint is that multiple leading medical device companies are expected to experience a performance turning point by 2026 due to policy easing, procurement clearance, new product and business expansion, and international layout [1] - The long-term investment opportunities in the medical device sector stem from innovation, internationalization, and mergers and acquisitions, with the sector's innovative and international capabilities gradually being recognized and valuations being reassessed [1] - The bidding environment for medical devices has significantly improved this year, and the bidding outlook for 2026 will depend on policy changes, with some leading companies likely to see stable revenue growth or accelerated improvement [1] Group 2 - In the high-value consumables segment, the timing of performance turning points varies among companies due to differences in the implementation of procurement policies, with some companies expected to see operational turning points in 2026 due to procurement clearance or new product catalysts [1] - The IVD sector's performance in 2026 will still be influenced by multiple policies, but improvements are expected compared to 2025, with the elimination of VAT impacts and stabilization of testing volumes [1] - In the low-value consumables segment, domestic business is expected to maintain steady growth, while overseas production capacity is anticipated to contribute to performance growth as it comes online [2] Group 3 - The home medical device industry is expected to continue its steady growth trend in 2026, with leading domestic companies likely to accelerate internationalization through team building and mergers and acquisitions [2]